Sign up to save tools and stay up to date with the latest in AI
bg
bg
1

Biongevity Celebrates Success of World's First Longevity Fitness Challenge in UAE & Announces Longevity Health Plans

Feb 26, 2025 - financialpost.com
Biongevity, a subsidiary of BioAro, successfully completed the world's first Longevity Fitness Challenge in the UAE, where 1,487 participants collectively walked 11,704,796 steps over 30 days, adding an estimated 1,170 days to their combined lifespans. The challenge highlighted the impact of consistent movement on longevity, with Mr. Muhammad Rizwan Arif emerging as the top performer. Biongevity also introduced an AI-powered facial recognition feature for blood pressure monitoring, enhancing cardiovascular health tracking.

Following the challenge, Biongevity announced plans to expand its presence in the UAE with comprehensive longevity programs. These programs focus on health optimization through multi-omics testing, AI-powered analysis, and regenerative medicine. Biongevity offers three exclusive longevity plans—Core, Plus, and Elite—ranging from AED 30,000 to AED 120,000 per year, providing services like genomic testing, stem cell therapy, and AI-driven health strategies. The company aims to shift healthcare from reactive to proactive, emphasizing healthspan optimization and age-related decline prevention.

Key takeaways:

  • Biongevity successfully completed the World's First Longevity Fitness Challenge in the UAE, with 1487 participants collectively walking 11,704,796 steps.
  • The challenge demonstrated the impact of consistent movement on longevity, with participants collectively adding an estimated 1,170 days to their combined lifespans.
  • Biongevity is expanding its presence in the UAE by launching longevity programs that integrate multi-omics testing, AI-powered analysis, and regenerative medicine.
  • Biongevity offers three exclusive longevity programs: Biongevity Core, Biongevity Plus, and Biongevity Elite, with pricing starting at AED 30,000 per year.
View Full Article

Comments (0)

Be the first to comment!